Literature DB >> 27484319

Promoting Global Health - Prevention and Treatment of Substance Abuse and HIV in Asia.

Ming D Li1,2, Yih-Ing Hser3, Zhiwei Chen4, Linda Chang5.   

Abstract

This special issue contains 20 papers including 3 Perspectives, 1 Brief Report, 6 Invited Reviews, and 10 Original Articles, which highlight the work by presenters at the second meeting of the biennial Conference Series to Promote Global Health held on April 22-24, 2015 in Hangzhou, Zhejiang, China. These papers focused on the prevalent substance misuse of amphetamine-type-stimulants and opioids, and the increasing prevalence of HIV-infection in Asian countries. The Conference Series is sponsored by the National Institute on Drug Abuse of the U.S. National Institutes of Health, with the goal of exchanging knowledge and ideas related to, and promoting international collaborative work on, the prevention and treatment of substance use disorders and HIV-infection, in order to promote health in Asian and Pacific Islanders and other populations.

Entities:  

Keywords:  Global health; HIV; Substance use disorders

Mesh:

Year:  2016        PMID: 27484319      PMCID: PMC5419042          DOI: 10.1007/s11481-016-9695-4

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  20 in total

Review 1.  Neuropharmacologic Approaches to Restore the Brain's Microenvironment.

Authors:  Weizhe Li; Hsin-I Tong; Santhi Gorantla; Larisa Y Poluektova; Howard E Gendelman; Yuanan Lu
Journal:  J Neuroimmune Pharmacol       Date:  2016-06-28       Impact factor: 4.147

Review 2.  A Perspective on Opioid Pharmacotherapy: Where We Are and How We Got Here.

Authors:  Walter Ling
Journal:  J Neuroimmune Pharmacol       Date:  2016-03-23       Impact factor: 4.147

3.  SIV Infection Impairs the Central Nervous System in Chinese Rhesus Macaques.

Authors:  Hang Liu; Qian-Hao Xiao; Jin-Biao Liu; Jie-Liang Li; Li Zhou; Qiao-Yang Xian; Yong Wang; Jing Zhang; Xu Wang; Wen-Zhe Ho; Ke Zhuang
Journal:  J Neuroimmune Pharmacol       Date:  2016-05-06       Impact factor: 4.147

4.  Glycosyl Phosphatidylinositol-Anchored C34 Peptide Derived From Human Immunodeficiency Virus Type 1 Gp41 Is a Potent Entry Inhibitor.

Authors:  Lihong Liu; Michael Wen; Qianqian Zhu; Jason T Kimata; Paul Zhou
Journal:  J Neuroimmune Pharmacol       Date:  2016-05-07       Impact factor: 4.147

Review 5.  Neuroimaging the Effectiveness of Substance Use Disorder Treatments.

Authors:  Elizabeth A Cabrera; Corinde E Wiers; Elsa Lindgren; Gregg Miller; Nora D Volkow; Gene-Jack Wang
Journal:  J Neuroimmune Pharmacol       Date:  2016-05-16       Impact factor: 4.147

Review 6.  Effects of HIV and Methamphetamine on Brain and Behavior: Evidence from Human Studies and Animal Models.

Authors:  Virawudh Soontornniyomkij; James P Kesby; Erin E Morgan; Amanda Bischoff-Grethe; Arpi Minassian; Gregory G Brown; Igor Grant
Journal:  J Neuroimmune Pharmacol       Date:  2016-08-02       Impact factor: 4.147

7.  Modulation Effect of HIV-1 Viral Proteins and Nicotine on Expression of the Immune-Related Genes in Brain of the HIV-1 Transgenic Rats.

Authors:  Zhongli Yang; Tanseli Nesil; Kaitlyn P Connaghan; Ming D Li; Sulie L Chang
Journal:  J Neuroimmune Pharmacol       Date:  2016-05-04       Impact factor: 4.147

Review 8.  Meta-Analysis of the COMT Val158Met Polymorphism in Major Depressive Disorder: Effect of Ethnicity.

Authors:  Maiqiu Wang; Yunlong Ma; Wenji Yuan; Kunkai Su; Ming D Li
Journal:  J Neuroimmune Pharmacol       Date:  2016-01-23       Impact factor: 4.147

Review 9.  Drug Abuse, HIV, and HCV in Asian Countries.

Authors:  Yih-Ing Hser; Di Liang; Yu-Ching Lan; Balasingam Kasinather Vicknasingam; Amit Chakrabarti
Journal:  J Neuroimmune Pharmacol       Date:  2016-03-21       Impact factor: 4.147

10.  A Smartphone Application Supporting Recovery from Heroin Addiction: Perspectives of Patients and Providers in China, Taiwan, and the USA.

Authors:  Marya Schulte; Di Liang; Fei Wu; Yu-Ching Lan; Wening Tsay; Jiang Du; Min Zhao; Xu Li; Yih-Ing Hser
Journal:  J Neuroimmune Pharmacol       Date:  2016-02-04       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.